News & Updates

Show Multimedia Only

Dalpiciclib a 1L option for HR-positive, HER2-negative advanced breast cancer regardless of menopausal status

05 Jul 2023 by

Adding dalpiciclib to an aromatase inhibitor (AI) significantly improves progression-free survival (PFS) vs an AI alone in first-line (1L) treatment of hormone receptor (HR)–positive, HER2-negative advanced breast cancer regardless of patients’ menopausal status, a phase III trial in 42 hospitals in China has shown.

Dalpiciclib a 1L option for HR-positive, HER2-negative advanced breast cancer regardless of menopausal status

05 Jul 2023

Semaglutide a useful weight-loss treatment option for men, women

05 Jul 2023

In the treatment of obesity, semaglutide works for both men and women, according to the results of a network meta-analysis.

Semaglutide a useful weight-loss treatment option for men, women

05 Jul 2023

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

The periconceptional use of methotrexate among men does not contribute to an increase in the risk of congenital anomalies, preterm birth (PTB), and being small for gestational age (SGA), but it may lead to a temporary decrease in fertility, according to a study.

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023 by

For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

04 Jul 2023

Cruciferous vegetable intake helps prevent NMIBC recurrence, progression

04 Jul 2023

Exposure to dietary isothiocyanates (ITCs) through the consumption of cruciferous vegetables (CVs) appears to contribute to the reduction in risks of recurrence and progression in patients with nonmuscle-invasive bladder cancer (NMIBC), suggests a study.

Cruciferous vegetable intake helps prevent NMIBC recurrence, progression

04 Jul 2023

Migraine tied to adverse pregnancy outcomes

04 Jul 2023 by

Pregnant women with migraine appear to have an increased likelihood of experiencing pre-eclampsia, low birth weight, peripartum mental illness, preterm birth, and placental abruption, according to a study presented at the recent RCOG 2023.

Migraine tied to adverse pregnancy outcomes

04 Jul 2023

$Ocular pain persists for some patients after refractive surgery$

Ocular pain persists for some patients after refractive surgery

04 Jul 2023

Nearly one in 10 patients report persistent ocular pain after refractive surgery, according to a study, noting several pre- and perioperative factors that can predict pain following the procedure.

Ocular pain persists for some patients after refractive surgery

04 Jul 2023

Specialized assessment programme benefits geriatric cancer patients

04 Jul 2023 by

The GOLDEN* programme, a geriatric oncology (GO) programme that has been used in a tertiary cancer centre in Singapore, appeared to effectively carry out its objective of optimizing care in older adults with cancer.

Specialized assessment programme benefits geriatric cancer patients

04 Jul 2023

Lower LDL-C target a better bet for adverse CV event prevention after stroke

04 Jul 2023

A treatment strategy of targeting a low-density lipoprotein cholesterol (LDL-C) of <70 mg/dL leads to a significant reduction in the composite of adverse cardiovascular (CV) events in patients who have had stroke as compared with an LDL-C target of 100 mg/dL, according to data from the Treat Stroke to Target (TST) trial.

Lower LDL-C target a better bet for adverse CV event prevention after stroke

04 Jul 2023

Mood disorders affect one in ten ICD patients

04 Jul 2023 by

Depression, anxiety, and post-traumatic stress disorder (PTSD) are highly prevalent in patients with an implantable cardioverter defibrillator (ICD), a meta-analysis has revealed.

Mood disorders affect one in ten ICD patients

04 Jul 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Dalpiciclib a 1L option for HR-positive, HER2-negative advanced breast cancer regardless of menopausal status

Dalpiciclib a 1L option for HR-positive, HER2-negative advanced breast cancer regardless of menopausal status

Semaglutide a useful weight-loss treatment option for men, women

Semaglutide a useful weight-loss treatment option for men, women

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

ADHD meds emerge as preferred option for reducing self-harm risk in BPD

Cruciferous vegetable intake helps prevent NMIBC recurrence, progression

Cruciferous vegetable intake helps prevent NMIBC recurrence, progression

Migraine tied to adverse pregnancy outcomes

Migraine tied to adverse pregnancy outcomes

Ocular pain persists for some patients after refractive surgery

Ocular pain persists for some patients after refractive surgery

Specialized assessment programme benefits geriatric cancer patients

Specialized assessment programme benefits geriatric cancer patients

Lower LDL-C target a better bet for adverse CV event prevention after stroke

Lower LDL-C target a better bet for adverse CV event prevention after stroke

Mood disorders affect one in ten ICD patients

Mood disorders affect one in ten ICD patients